Key facts
| Price (PPV) | 4,574 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | somatrogon |
| Class | Pituitary and hypothalamic hormones |
| ATC code | H01AC08 |
| Manufacturer | PFIZER MAROC |
| Presentation | Boite d'un stylo pré-rempli de 1.2 ML |
| Hospital price | 4,297 MAD |
| Data collected on | 9/8/2026 |
Indications
Ngenla est indiqué dans le traitement de l’enfant et de l’adolescent âgé de 3 ans et plus présentant un trouble de la croissance dû à une sécrétion insuffisante d’hormone de croissance.
Find an open pharmacy
On-call pharmacies near you
About Ngenla 60 mg / 1.2 ml
Ngenla 60 mg / 1.2 ml belongs to the pituitary and hypothalamic hormones therapeutic class. In Morocco, this drug is marketed by PFIZER MAROC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Ngenla 60 mg / 1.2 ml, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Ngenla 60 mg / 1.2 ml
Answers to common questions from Moroccan patients about this drug.